Cipla gets US FDA approval for dimethyl fumarate DR capsules
It is indicated for the treatment of relapsing forms of multiple sclerosis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA approval
Zydus Cadila gets US FDA approval for Doxorubicin Hydrochloride Liposome Injection
Liposomal doxorubicin is a chemotherapeutic agent that is used alone or with other treatments/medications to treat certain types…
Alembic Pharma gets tentative USFDA approval for Treprostinil injection
It is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise
Roche’s Genentech gets US FDA approval for Gavreto (pralsetinib)
The drug is used to treat metastatic RET fusion-positive non-small cell lung cancer
Strides gets USFDA approval for Ursodiol tablets
Product to be launched immediately and marketed by Strides Pharma in the US market
US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment
Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)
Mylan announces launch of generic version of Biogen’s Tecfidera
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)
Aleor Dermaceuticals receives USFDA tentative approval for antifungal medication
Tavaborole topical solution, 5% is indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or…
Unichem gets US FDA approval for Tolterodine Tartrate tablets
These tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and…
GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma
BLENREP is the fifth major medicine approval for GSK in 2020